Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
Pneumolysin-damaged cells benefit from non-homogeneous toxin binding to cholesterol-rich membrane domains
Graphical abstract
Introduction
Streptococcus pneumoniae is a potent human pathogen [1,2]. Its cholesterol-dependent cytolysin (CDC), pneumolysin (PLY) is instrumental for breaching the host's epithelial barrier and for the incapacitation of the immune system [[3], [4], [5]]. CDCs are secreted as soluble monomers and bind to cholesterol within eukaryotic plasmalemma [6,7]. After oligomerization, they initially form inactive pre-pores that eventually undergo a transition to active membrane-perforating pores [6,8].
The plasmalemmal lipid bilayer is believed to display an inhomogeneous distribution of different lipid species [9,10]. Aided by protein-lipid and lipid-lipid interactions, cholesterol-rich microdomains embedded in a saturated lipid environment (lipid rafts) alternate with regions of low cholesterol surrounded by unsaturated phospholipids [[11], [12], [13], [14]]. Remaining beyond the resolution limit of conventional light microscopy [9], short-living and highly dynamic, lipid rafts could be stabilized by protein-ligands, which, in turn, could trigger raft coalescence [15].
While playing an important role in cellular homeostasis [4], membrane rafts are also hijacked by pathogens to harm a host cell: plasmalemmal binding of CDCs and their oligomerization is potentiated within membrane lipid rafts [2,[15], [16], [17], [18], [19]].
Nucleated cells are capable of eliminating PLY-induced lesions by shedding damaged, PLY- containing plasmalemmal patches into the extracellular milieu in form of microvesicles [1,20,21]. Recently, we have shown that the vast majority of shed, microvesicle-associated PLY is present in the form of inactive pre-pores; whereas active PLY-pores featuring a perforated membrane account for only 10% of the total PLY [22]. This finding is surprising considering that the process of shedding is triggered by Ca2+-entry from the extracellular milieu following plasmalemmal perforation and is therefore expected to positively discriminate for active pores versus inactive pre-pores [21,22].
Here, using live-cell imaging in combination with model membrane experiments under microfluidic control we have analyzed potential mechanisms that might be responsible for the preferential shedding of inactive PLY-pre-pores in the process of plasmalemmal repair. We provide evidence for the existence of distinct plasmalemmal domains that are capable to attract PLY at a high local concentration. Furthermore, we show that in artificial membranes PLY preferentially targets cholesterol-rich domains and their boundaries. It is feasible that such domains might be either permanently present within the plasmalemma of nucleated cells as a result of protein-driven lipid segregation, or are a result of PLY-induced self-association of nanoscale, lipid-driven lipid inhomogeneities such as membrane rafts. Our findings provide further insights into the functioning of the cellular repair machinery that benefits from an inhomogeneous distribution of PLY on the plasmalemma and triggers an effective antibacterial defense [1,20].
Section snippets
Inhomogeneous distribution of PLY on the plasmalemma of nucleated cells
Treatment of cultured human cells of various origins with fluorescently labelled PLY revealed a strikingly inhomogeneous distribution of the toxin within the plane of the cell's plasmalemma: distinct, clearly defined sub-micrometer domains of highly concentrated PLY, alternated with domains that were virtually toxin-free (Fig. 1a, Fig. SI 1a). Remarkably aerolysin, a pore-forming toxin, secreted by Aeromonas hydrophila, which does not bind to cholesterol but instead uses a
Discussion
We show that binding of the pore-forming toxin pneumolysin (PLY) to human cells occurs within distinct, clearly defined plasmalemmal areas that alternate with virtually toxin-free regions. The segregation between PLY-rich and PLY-depleted plasmalemmal domains occurs during the PLY-binding stage and persists through the process of active pore-formation. We further show that PLY-segregation is not driven by the Ca2+-dependent repair proteins that are responsible for the elimination of PLY-pores.
Materials
1,2-Dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), N-palmitoyl-d-erythro-sphingosylphosphorylcholine (PSM), N-oleoyl-d-erythro-sphingosylphosphorylcholine (OSM) were purchased from Avanti Polar Lipids (Alabaster, AL, USA). Cholesterol, FITC-dextran (70 kDa), Dithiothreitol (DTT), Dulbecco's PBS and bovine serum albumin (BSA) come from Sigma-Aldrich (Munich, Germany). Naphtho[2,3-a]pyrene (NAP) was supplied by TCI Deutschland GmbH and
Abbreviations
SM sphingomyelin
PC phosphatidylcholine
PSM N-palmitoyl- sphingosylphosphorylcholine
OSM N-oleoyl-sphingosylphosphorylcholine
DOPC di-oleoyl phosphatidylcholine
DPPC di-palmitoyl phosphatidylcholine
PFT pore-forming toxin
CDC cholesterol dependent cytolysin
NAP Naphtho[2,3-a]pyrene
DiI Dioctadecyl-tetramethylindo-carbocyanine
hRBC human red blood cell
MWCO molecular weight cut-off
CLSM confocal laser scanning microscopy
BP bandpass
MBS main beam splitter
Transparency document
Acknowledgements
We gratefully acknowledge funding from the Novartis Foundation for Medical-Biological Research (16B100 to E.B·B), the Swiss National Science Foundation (SNF 31003A_159414, to A.D.), the Gebert Rüf Foundation (to A.D.), the European Research Council (ERC Consolidator Grant No. 681587, HybCell, to P.S.D.) and the University of Bern (UniBE Initiator Grant to P.D.). We would also like to thank Christoph Bärtschi for constructing the pressure valve control instrument required to operate the
Author contributions
P.D. and S.B. performed and analyzed in vitro experiments. P.D., H.W., V.S.B., R.K. and E.B.B. performed and analyzed cell culture experiments. R.S. and P.D. generated the mCherry-PLY-construct. P.D., A.D. and E.B.B. designed the study and wrote the paper. P.S.D., A.D. and E.B.B. coordinated the study. All authors analyzed and discussed the results and commented on the manuscript.
Competing financial interests
The authors declare no competing financial interests.
References (46)
- et al.
Defying death: cellular survival strategies following plasmalemmal injury by bacterial toxins
Semin. Cell Dev. Biol.
(2015) - et al.
Structural basis of pore formation by the bacterial toxin pneumolysin
Cell
(2005) - et al.
The role of cholesterol in the activity of pneumolysin, a bacterial protein toxin
Biophys. J.
(2004) - et al.
Self-interaction of pneumolysin, the pore-forming protein toxin of Streptococcus pneumoniae
J. Mol. Biol.
(1998) - et al.
Sphingolipid topology and the dynamic organization and function of membrane proteins
FEBS Lett.
(2010) - et al.
Bacterial subversion of lipid rafts
Curr. Opin. Microbiol.
(2004) - et al.
How interaction of Perfringolysin O with membranes is controlled by sterol structure, lipid structure, and physiological low pH: insights into the origin of Perfringolysin O-lipid raft interaction
J. Biol. Chem.
(2008) - et al.
Plasma membrane repair: the adaptable cell life-insurance
Curr. Opin. Cell Biol.
(2017) - et al.
Active release of pneumolysin prepores and pores by mammalian cells undergoing a Streptococcus pneumoniae attack
BBA-Gen. Subjects
(2016) - et al.
The glycan core of GPI-anchored proteins modulates aerolysin binding but is not sufficient: the polypeptide moiety is required for the toxin–receptor interaction
FEBS Lett.
(2002)
Membrane fluidity and its roles in the perception of environmental signals
Biochim. Biophys. Acta Biomembr.
A microscopic interaction model of maximum solubility of cholesterol in lipid bilayers
Biophys. J.
Maximum solubility of cholesterol in phosphatidylcholine and phosphatidylethanolamine bilayers
Biochim. Biophys. Acta Biomembr.
Model membrane thermodynamics and lateral distribution of cholesterol: from experimental data to Monte Carlo simulation
Meth. Enzymol.
Separation of liquid phases in giant vesicles of ternary mixtures of phospholipids and cholesterol
Biophys. J.
Seeing spots: complex phase behavior in simple membranes
BBA-Mol. Cell Res.
Regulation of calcium channel activity by lipid domain formation in planar lipid bilayers
Biophys. J.
Lipid phase coexistence favors membrane insertion of Equinatoxin-II, a pore-forming toxin from Actinia equina
J. Biol. Chem.
Annexins as intracellular calcium sensors
Cell Calcium
Gel-assisted formation of giant unilamellar vesicles
Biophys. J.
Lipid segregation and membrane budding induced by the peripheral membrane binding protein Annexin A2
J. Biol. Chem.
Pore-forming toxins: ancient, but never really out of fashion
Nat. Rev. Micro.
The membrane attack complex, perforin and cholesterol-dependent cytolysin superfamily of pore-forming proteins
J. Cell Sci.
Cited by (11)
Actin dynamics and myosin contractility during plasma membrane repair and restoration: Does one ring really heal them all?
2019, Current Topics in MembranesCitation Excerpt :Bleb formation and subsequent shedding could also be potentiated by direct modification of PM shape, as SLO permeabilization was found to lead to a 1.5-fold increase in the activity of neutral sphingomyelinase (nSMase)-2 to the inner leaflet of the PM (Walev, Tappe, Gulbins, & Bhakdi, 2000), which in turn leads to a concave curvature of the PM caused by the formation of ceramide-rich domains on the inner surface of the PM (Draeger & Babiychuk, 2013). It is, however, worth noting that this particular model has never been directly validated, and that others have shown the process to be passive, as some have also observed calcium-independent recruitment of the pores into specific, cholesterol-rich domains (Drucker et al., 2018; Keyel et al., 2011; Romero et al., 2017). This process is also likely to be supplemented by other more robust repair processes such as the endocytosis-mediated repair described in the following sub-section.
Plasma membrane integrity: implications for health and disease
2021, BMC BiologyProgress in research on novel Streptococcus pneumoniae vaccines using pneumolysin as antigen
2021, Chinese Journal of Biologicals